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Objective: To systematically analyse the effectiveness of delayed-absorbable (Polydioxanone; PDS) versus
non-absorbable (Polypropylene; Prolene, and Nylon) for abdominal fascial closure in patients undergoing
laparotomy.
Methods: Randomised trials evaluating PDS versus Prolene/Nylon for abdominal fascial closure were
selected and analysed by using the statistical tool RevMan where summative data was expressed as
odds ratio (OR).
Results: Eight randomised trials encompassing 4261 patients undergoing laparotomy closure with either
PDS or Prolene/Nylon were retrieved. There was no statistically signiﬁcant heterogeneity among trials. In
the ﬁxed effect model PDS was comparable to Prolene/Nylon in terms of risk of incisional hernia (OR,
1.10; 95% CI, 0.87, 1.37; z ¼ 0.79; p ¼ 0.43), wound dehiscence (OR, 1.04; 95% CI, 0.67, 1.62; z ¼ 0.19;
p ¼ 0.85), peri-operative complications (OR, 0.94; 95% CI, 0.66, 1.33; z ¼ 0.37; p ¼ 0.71), suture sinus
formation (OR, 0.58; 95% CI, 0.33, 1.04; z ¼ 1.84; p ¼ 0.07) and surgical site infection (OR, 0.98; 95% CI,
0.68, 1.39; z ¼ 0.14; p ¼ 0.89). Subgroup analysis separately comparing Prolene and Nylon with PDS
supported same outcome.
Conclusion: PDS and Prolene/Nylon are equally effective for the closure of abdominal fascia following
laparotomy. Given that there are no signiﬁcant differences between two suture materials, further studies
may be conducted to evaluate their cost-effectiveness and measurement of health-related quality of life
instead of analysing their effectiveness in laparotomy closure.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Incisional hernia is a frequent complication of abdominal surgery,
with a reported incidence of 3e13% of patients following lapa-
rotomy.1e4 In the United States of America, approximately 4e5
million laparotomies are performed annually,4 leading to at least
400,000e500,000 incisional hernias, of which approximately
200,000 repairs are performed.4,5 In the Netherlands, 100,000 lapa-
rotomies and 3900 incisional hernia repairs are performed annually.6
In the United Kingdom, more than 124,000 laparotomies and 7000
incisional hernia repairs were performed in 2005e2006 with both
open and laparoscopic techniques.7 Thus about 4% of patients
undergoing a laparotomy require additional surgery to repair an
incisional hernia. Whenmorbidity is added to the vast numbers and
the tremendous costs associated with incisional hernia repair,8e12 iting, Worthing Hospital, West
030, 07891667608 (Mobile);
Sajid).
ciates Ltd. Published by Elsevier Ltbecomes quite clear that effective preventive strategies may play
a vital role to save healthcare resources by reducing the incidence of
incisional hernia. Development of incisional hernia following lapa-
rotomy is multifactorial. These factors may be classiﬁed into patient
related, biological factors and surgical technique related.13e16 Patient
related factors include age, higher body mass index, synchronous
presence of abdominal aortic aneurysm and multiple co-morbid-
ities.17e20 Biological factors include the capacity for normal collagen
synthesis and organization to affect sound biological repair. Abno-
rmal biological healing of fascial sheath results in the development of
incisional hernia.21e24 Therefore, biological factors are less amenable
to modiﬁcations. Operative and technical factors may be considered
the weakest link in the development of incisional hernia which
should form the highest priority in preventive strategies.
Several systematic reviews25e30 have examined the type of
suture used for abdominal fascial closure but none have success-
fully recommended an agreed suture technique and suture type.
The objective of this review is to systematically analyse only those
randomised controlled trials which have evaluated the efﬁcacy of
the most commonly used suture material (in the United Kingdom)d. All rights reserved.
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REVIEWfor abdominal fascial closure, that is monoﬁlamentous slowly-
absorbable Polydioxanone (PDS) versus monoﬁlamentous non-
absorbable Polypropylene (Prolene) and Nylon.
2. Methods
Relevant prospective randomized controlled trials on the use of PDS versus
Prolene/Nylon for abdominal fascial closure following laparotomy until April 2011
were included in this review. The Cochrane Colorectal Cancer Group (CCCG)
Controlled Trial Register, the Cochrane Central Register of Controlled Trials
(CENTRAL) in The Cochrane Library, Medline, Embase and Science Citation Index
Expanded were searched until April 2011 using the medical subject headings
(MeSH) terms “laparotomy closure”, and “fascial sheath closure”. These headings
were used in combination with “slowly-absorbable suture”, “non-absorbable
suture”, “polydioxanone”, “PDS”,“polypropylene”, and “prolene”. A ﬁlter for
identifying relevant studies recommended by The Cochrane Collaboration31 was
used to ﬁlter out irrelevant studies in Medline and Embase. The references of the
included studies were searched to identify further trials. The software package
RevMan 5.0.132 provided by The Cochrane Collaboration was used for analysis. The
odds ratio (OR) with 95 per cent conﬁdence interval (CI) was calculated for binary
data variables. The random effects model33 and the ﬁxed effect model34 were used
to calculate the combined outcome in both binary and continuous variables. In
case of heterogeneity, only the results of the random effects model were reported.
Heterogeneity was explored using the c2 test, with signiﬁcance set at p< 0$05, and
quantiﬁed35 using I2 with a maximum value of 30% identifying low heteroge-
neity.31 The Mantel-Haenszel method was used for the calculation of OR under the
ﬁxed effect model, and the DerSimonian/Laired method was used for the calcu-
lation of OR under the random effect model.36 In a sensitivity analysis, 0.5 was
added to each cell frequency for trials in which no event occurred in either thePotentially relevant trials identified for 
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Fig. 1. Quorum diagram showingtreatment or control group, according to the method recommended by Deeks
et al.37 The estimate of the difference between both techniques was pooled
depending upon the effect weights in results determined by each trial estimate
variance. A forest plot (Figs. 3e17) was used for the graphical display of results
from the meta-analysis. The square around the estimate stands for the accuracy of
the estimation (sample size) and the horizontal line represents the 95% CI. We also
performed subgroup analysis on trials where comparison between PDS versus
Prolene and PDS versus Nylon was made separately to evaluate the inﬂuence of
individual suture material.
3. Results
Eight studies38e45 encompassing 4261 patients undergoing
laparotomyclosurewith either PDS or Prolene/Nylonwere retrieved
from the electronic databases (Fig. 1). There were 2195 patients in
PDS group and 2066 patients in Prolene/Nylon group. The charac-
teristics of these trials are given in Table 1. Variables used to achieve
a combined outcome are given in Table 2. On subgroup analysis,
combined outcome was achieved by a separate meta-analysis of 4
trials38,39,42,44 comparing the effectiveness of PDS (863 patients)
versus Prolene (865 patients). Furthermore, combined outcomewas
also achieved after a separate meta-analysis of 4 trials40,41,43,45
comparing the effectiveness of PDS (1332 patients) versus Nylon
(1201 patients) and difference between outcomes of these two
groups was critically assessed to quantify bias based on these two
suture materials.Trials excluded n =28 
ls on the use of other types of sutures used for 
osure 
Trials excluded n = 31 
uplicate publications of same trials (11), 
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trial selection methodology.
Table 1
Characteristics of included trials.
Trial Type
of trial
Country Surgical procedures Suture comparison Follow-up
duration
Reported outcomes
Bloemen 2011 RCT Netherlands Both elective
and emergency
laparotomy
Polydioxanone 1/0 versus
Polypropylene 1/0 Mass closure
Polydioxanone:
34.5(31.6e37.3)
Polypropylene:
33.3(30.5e36.0)
Wound infection
Peri-operative complications
Wound dehiscence
Suture sinus
Incisional hernia
Cameron 1987 RCT UK Midline laparotomy
for various abdominal
procedures
Polydiaxanone 1 versus
Polypropylene 1 Mass closure
14.70 months Wound infection
Per-ioperative complications
Wound dehiscence
Suture sinus
Incisional hernia
Docobo-Durantez
2006
RCT Spain Laparotomy for
Hepatobiliopancreatic diseases
and liver transplantation
Polydioxanone 1 versus
Nylon 1 Mass closure
18 months Wound infection
Peri-operative complications
Wound dehiscence
Suture sinus
Incisional hernia
Israelsson 1994 RCT Iceland
Sweden
Midline laparotomy for various
abdominal procedures
Polydioxanone 2 versus
Nylon 1 Mass closure
12 months Wound infection
Peri-operative complications
Wound dehiscence
Suture sinus
Incisional hernia
Krukowski 1987 RCT UK Midline laparotomy for various
abdominal procedures
Polydiaxanone 1 versus
Polypropylene 1
12 months Wound infection
Peri-operative complications
Wound dehiscence
Suture sinus
Incisional hernia
Leaper 1985 RCT UK Midline and transverse laparotomy
for various abdominal procedures
Polydioxanone 1 versus
Nylon 1 Mass closure
6 months Wound infection
Peri-operative complications
Wound dehiscence
Suture sinus
Incisional hernia
Mirza 2003 RCT UAE Midline and transverse laparotomy
for various abdominal procedures
Polydiaxanone 1 versus
Polypropylene 1 Mass closure
12 months Wound infection
Peri-operative complications
Wound dehiscence
Suture sinus
Incisional hernia
Wissing 1987 RCT Netherlands All midline laparotomies:
emergency and elective
Polydioxanone 1 versus
Nylon 1 Mass closure
12 months Wound infection
Peri-operative complications
Wound dehiscence
Suture sinus
Incisional hernia
Table 2
Outcome variables.
Trial Number
of patients
Incisional
hernia
Surgical site
infection
Suture
sinus
Peri-operative
complications
30-day wound
dehiscence
Bloemen 2011
Polydiaxanone 267 58/267 18/267 5/267 41/267 18/267
Polypropylene 256 45/256 14/256 3/256 26/256 9/256
Cameron 1987
Polydiaxanone 143 10/143 12/143 0/143 44/143 1/143
Polypropylene 141 11/141 21/141 1/141 47/141 9/141
Docobo-Durantez 2006
Polydiaxanone 451 5/65 21/451 Not 25/451 4/451
Nylon 319 2/42 20/319 reported 23/319 2/319
Israelsson 1994
Polydiaxanone 405 49/325 38/405 1/405 8/405 2/405
Nylon 408 50/318 35/408 1/408 11/408 3/408
Krukowski 1987
Polydiaxanone 374 22/285 13/374 0/374 16/374 3/343
Polypropylene 383 28/295 27/383 1/383 35/383 7/362
Leaper 1985
Polydiaxanone 107 1/107 18/106 0/107 19/107 1/106
Nylon 97 0/97 9/97 0/97 9/97 0/97
Mirza 2003
Polydiaxanone 79 5/79 8/79 2/79 11/79 1/79
Polypropylene 85 4/85 10/85 11/85 23/85 2/85
Wissing 1987
Polydiaxanone 370 37/281 43/370 11/281 67/281 13/370
Nylon 377 31/299 27/377 23/299 58/299 8/377
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REVIEW3.1. Methodological quality of included studies
The methodological quality of included trials was initially
assessed by the published guideline of SIGN (Scottish Intercollegiate
GuidelinesNetwork) andRangel et al.46,47 All trials scored from11 to
15 amaximumof 19moderates to good strengthof each randomized
controlled trial. Based on the quality of included randomised
controlled trials,38e45 the strength and summary of evidence was
further evaluated by GradePro,48 a statistical tool provided by
Cochrane Collaboration (Fig. 2). The Mantel-Haenszel ﬁxed effect
model was used to compute robustness and susceptibility to an
outlier among these trials. The allocation concealment and blindingFig. 2. Summary and strength of the evidenof investigator or assessor were not clearly reported as is often the
case in trial evaluating surgical procedures. Qualitatively the results
of this review may be considered relatively weaker. There was no
statistically signiﬁcant heterogeneity (clinical or methodological
diversity) amongst trials except in case of peri-operative compli-
cations including surgical site infection.
3.2. Incidence of incisional hernia (PDS versus Prolene/Nylon)
There was no heterogeneity [chi2 ¼ 4.31, df ¼ 7, (p ¼ 0.74);
I2¼ 0%] among trials. Therefore, in the ﬁxed effects model (OR,1.11;
95% CI, 0.89, 1.39; z ¼ 0.92; p ¼ 0.36; Fig. 3), there was no statisticalce from trials analysed on GradePro.
Fig. 3. Incisional hernia (PDS versus Prolene/Nylon).
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both types of sutures for abdominal fascial closure.
3.3. Surgical site infection rate (PDS versus Prolene/Nylon)
There was a signiﬁcant heterogeneity [Tau2 ¼ 0.14, chi2 ¼ 15.92,
df ¼ 7, (p < 0.03); I2 ¼ 56%] among trials. Therefore, in the random
effects model (OR, 0.97; 95% CI, 0.68, 1.39; z¼ 0.16; p¼ 0.88; Fig. 4),
there was no statistical difference in surgical site infection rate
following the use of both types of sutures.
3.4. Suture sinus development rate (PDS versus Prolene/Nylon)
There was no heterogeneity [chi2 ¼ 4.70, df ¼ 5, (p ¼ 0.45);
I2 ¼ 0%] among trials. Therefore, in the ﬁxed effects model (OR,
0.49; 95% CI, 0.29, 0.85; z ¼ 2.54; p ¼ 0.01; Fig. 5), there was
statistically signiﬁcant higher risk of suture sinus development
following the use of Prolene/Nylon compared to PDS.
3.5. Peri-operative complications (PDS versus Prolene/Nylon)
There was a signiﬁcant heterogeneity [Tau2 ¼ 0.19, chi2 ¼ 21.66,
df¼ 7, (p< 0.003); I2¼ 68%] among trials. Therefore, in the random
effects model (OR, 0.89; 95% CI, 0.61, 1.30; z¼ 0.60; p¼ 0.55; Fig. 6),
there was no statistical difference in the incidence of peri-operative
complications following the use of both types of sutures.Fig. 4. Surgical site infection (P3.6. Peri-operative wound dehiscence (PDS versus Prolene/Nylon)
There was no heterogeneity [chi2 ¼ 10.70, df ¼ 7,
(p ¼ 0.15); I2 ¼ 35%] among trials. Therefore, in the ﬁxed
effects model (OR, 1.05; 95% CI, 0.68, 1.62; z ¼ 0.20; p ¼ 0.84;
Fig. 7), there was no statistical difference in the incidence of
peri-operative wound dehiscence following the use of both
types of sutures.3.7. Incidence of incisional hernia (PDS versus Prolene)
There was no heterogeneity [chi2 ¼ 2.05, df ¼ 3, (p ¼ 0.56);
I2 ¼ 0%] among trials. Therefore, in the ﬁxed effects model
(OR, 1.08; 95% CI, 0.79, 1.48; z ¼ 0.47; p ¼ 0.64; Fig. 8), there
was no statistical difference in the incidence of incisional
hernia the use of both types of sutures for abdominal fascial
closure.3.8. Surgical site infection rate (PDS versus Prolene)
There was no heterogeneity [chi2 ¼ 4.46, df ¼ 3, (p ¼ 0.22);
I2 ¼ 33%] among trials. Therefore, in the ﬁxed effects model (OR,
0.69; 95% CI, 0.48, 1.00; z ¼ 1.94; p ¼ 0.05; Fig. 9), there was no
statistical difference in surgical site infection rate following the use
of both types of sutures.DS versus Prolene/Nylon).
Fig. 6. Peri-operative complications (PDS versus Prolene/Nylon).
Fig. 7. Wound dehiscence (PDS versus Prolene/Nylon).
Fig. 5. Suture sinus formation (PDS versus Prolene/Nylon).
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Fig. 9. Surgical site infection (PDS versus Prolene).
Fig. 8. Incisional hernia (PDS versus Prolene).
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There was no heterogeneity [chi2 ¼ 4.48, df ¼ 3, (p ¼ 0.21);
I2 ¼ 33%] among trials. Therefore, in the ﬁxed effects model (OR,
0.47; 95% CI, 0.20, 1.10; z ¼ 1.74; p ¼ 0.08; Fig. 10), there was no
statistical difference in the incidence of suture sinus development
following the use of both types of sutures materials.
3.10. Peri-operative complications (PDS versus Prolene)
There was a signiﬁcant heterogeneity [Tau2 ¼ 0.29, chi2 ¼ 12.69,
df¼ 3, (p< 0.005); I2¼ 76%] among trials. Therefore, in the random
effectsmodel (OR, 0.83; 95% CI, 0.47,1.46; z¼ 0.65; p¼ 0.51; Fig.11),
there was no statistical difference in the incidence of peri-operative
complications following the use of both types of sutures.Fig. 10. Suture sinus formatio3.11. Peri-operative wound dehiscence (PDS versus Prolene)
There was a signiﬁcant heterogeneity [Tau2 ¼ 1.40, chi2 ¼ 9.87,
df ¼ 3, (p < 0.02); I2 ¼ 70%] among trials. Therefore, in the random
effects model (OR, 0.49; 95% CI, 0.12, 2.09; z¼ 0.96; p¼ 0.34; Fig.12),
there was no statistical difference in the incidence of peri-operative
wound dehiscence following the use of both types of sutures.
3.12. Incidence of incisional hernia (PDS versus nylon)
There was no heterogeneity [chi2 ¼ 1.44, df ¼ 3, (p ¼ 0.70);
I2¼ 0%] among trials. Therefore, in the ﬁxed effects model (OR,1.12;
95% CI, 0.81,1.54; z¼ 0.68; p¼ 0.49; Fig. 13), there was no statistical
difference in the incidence of incisional hernia following the use of
both types of sutures.n (PDS versus Prolene).
Fig. 12. Wound dehiscence (PDS versus Prolene).
Fig. 11. Peri-operative complications (PDS versus Prolene).
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There was no heterogeneity [chi2 ¼ 5.68, df ¼ 3, (p ¼ 0.13);
I2 ¼ 47%] among trials. Therefore, in the ﬁxed effects model (OR,
1.25; 95% CI, 0.94, 1.67; z ¼ 1.56; p ¼ 0.12; Fig. 14), there was no
statistical difference in the incidence of developing surgical site
infection following the use of both types of sutures.
3.14. Suture sinus development rate (PDS versus Nylon)
There was no heterogeneity [chi2 ¼ 0.24, df ¼ 1, (p ¼ 0.62);
I2 ¼ 0%] among trials. Therefore, in the ﬁxed effects model (OR,
0.51; 95% CI, 0.25, 1.04; z ¼ 1.85; p ¼ 0.06; Fig. 15), there was no
statistical difference in the incidence of suture sinus development
following the use of both types of sutures for abdominal fascial
closure in laparotomy.Fig. 13. Incisional hernia3.15. Peri-operative complications (PDS versus Nylon)
There was no heterogeneity [chi2 ¼ 5.28, df ¼ 3, (p ¼ 0.15);
I2 ¼ 43%] among trials. Therefore, in the ﬁxed effects model (OR,
1.14; 95% CI, 0.86, 1.52; z ¼ 0.91; p ¼ 0.37; Fig. 16), there was no
statistical difference in the incidence of peri-operative complica-
tions following the use of both types of sutures for abdominal
fascial closure.
3.16. Peri-operative wound dehiscence (PDS versus Nylon)
There was no heterogeneity [chi2 ¼ 1.73, df ¼ 3, (p ¼ 0.63);
I2¼ 0%] among trials. Therefore, in the ﬁxed effects model (OR,1.35;
95% CI, 0.68, 2.67; z¼ 0.87; p¼ 0.38; Fig.17), therewas no statistical
difference in the incidence of peri-operative wound dehiscence
following the use of both types of sutures.(PDS versus Nylon).
Fig. 15. Suture sinus formation (PDS versus Nylon).
Fig. 14. Surgical site infection (PDS versus Nylon).
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A subgroup analysis was performed on trials with follow-up of
more than 1 year because a number of incisional hernias develop
later than one year after laparotomy. There was no heterogeneity
[chi2 ¼ 4, df ¼ 6, (p ¼ 0.68); I2 ¼ 0%] among trials. Therefore, in the
ﬁxed effects model (OR, 1.10; 95% CI, 0.88 1.38; z ¼ 0.87; p ¼ 0.38),
there was no statistical difference in the incidence of incisional
hernia following the use of both types of sutures for abdominal
fascial closure.
3.18. Other relevant variables
Although the authors of this review intended to analyse data of
other relevant and important variables such as cost-effectiveness,
health-related quality of life measurement, length of hospitalFig. 16. Peri-operative complicastay, operative time, long-term follow-up and re-admission rate
due intra-abdominal adhesions. These calculations were virtually
impossible to perform because of insufﬁcient data reporting.
4. Discussion
This meta-analysis has demonstrated that PDS, Prolene and
Nylon all are equally effective for abdominal fascial closure. Risk of
incisional hernia, wound dehiscence, peri-operative complications,
suture sinus formation, and surgical site infection do not differ
signiﬁcantly for different suture materials. Subgroup analysis
comparing PDS with both Prolene and Nylon also suggest equiva-
lence. There is a lack of agreement within the surgical fraternity
about the ideal abdominal fascial closure technique. Several meta-
analyses of variable quality25e30 have reported confusing and
conﬂicting recommendations. Studies have compared the use oftions (PDS versus Nylon).
Fig. 17. Wound dehiscence (PDS versus Nylon).
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absorbable, monoﬁlament versus multiﬁlament and the use of steel
wires for laparotomy closure but without any solid conclusion. The
ﬁndings of our review correlate well with one meta-analysis27
published in 2002 supporting the use of slowly-absorbable suture
material. This is further supported by Diener et al25 favouring the
use of delayed-absorbable suture material like PDS. In contrast,
Hodgson et al28 favour the use of non-absorbable Prolene and
Nylon. We consider this meta-analysis a valuable guide in current
surgical practice for the surgical community because the most
commonly used suture materials were compared and a conclusive
outcome could be reached to attain valid recommendations. A
recently published high quality randomised controlled38 trial
favours our conclusion considerably but the incidence of incisional
hernia was reported higher between both groups because of
difference in baseline characteristics referring towards higher
number of recruited patients with chronic obstructive pulmonary
disease.
No further trials are required for the evaluation of suturematerial
in abdominal fascial closure according to the results of summative
outcomes of this review. Future randomised trials may be aimed to
evaluate variables like cost-effectiveness, health-related quality of
life measurement, length of hospital stay, operative time, long-term
follow-up and re-admission rate due to intra-abdominal adhesions.
Furthermore, research may be directed towards closure strategy in
emergency versus elective laparotomy closure, new suture material,
and the use of prophylactic biosynthetic meshes in a group of high
risk population like patients with obesity, chronic obstructive
pulmonary disease, metabolic syndromes, abdominal aortic aneu-
rysm and patients with previous laparotomy.13e25
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